Nashville General — Nashville, Tennessee

Public research footprint of Nashville General, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Breast Neoplasms · Breast Cancer · Non-small Cell Lung Cancer · TNBC - Triple-Negative Breast Cancer

Recently updated registry entries

NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)
NCT06745882 — Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nashville General?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.